Information Journal Paper
APA:
CopyAHMADIEH, H., RAMEZANI, A., SHOEYBI, N., BIZHANZADEH, B., TABATABAEI, A., & AZARMINA, M.. (2008). INTRAVITREAL BEVACIZUMAB WITH OR WITHOUT TRIAMCINOLONE FOR REFRACTORY DIABETIC MACULAR EDEMA; A PLACEBOCONTROLLED, RANDOMIZED CLINICAL TRIAL. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (ALBRECHT VON GRAEFES ARCHIV FUR KLINISCHE UND EXPERIMENTELLE OPHTHALMOLOGIE), 246(4), 483-489. SID. https://sid.ir/paper/555692/en
Vancouver:
CopyAHMADIEH H., RAMEZANI A., SHOEYBI N., BIZHANZADEH B., TABATABAEI A., AZARMINA M.. INTRAVITREAL BEVACIZUMAB WITH OR WITHOUT TRIAMCINOLONE FOR REFRACTORY DIABETIC MACULAR EDEMA; A PLACEBOCONTROLLED, RANDOMIZED CLINICAL TRIAL. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (ALBRECHT VON GRAEFES ARCHIV FUR KLINISCHE UND EXPERIMENTELLE OPHTHALMOLOGIE)[Internet]. 2008;246(4):483-489. Available from: https://sid.ir/paper/555692/en
IEEE:
CopyH. AHMADIEH, A. RAMEZANI, N. SHOEYBI, B. BIZHANZADEH, A. TABATABAEI, and M. AZARMINA, “INTRAVITREAL BEVACIZUMAB WITH OR WITHOUT TRIAMCINOLONE FOR REFRACTORY DIABETIC MACULAR EDEMA; A PLACEBOCONTROLLED, RANDOMIZED CLINICAL TRIAL,” GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (ALBRECHT VON GRAEFES ARCHIV FUR KLINISCHE UND EXPERIMENTELLE OPHTHALMOLOGIE), vol. 246, no. 4, pp. 483–489, 2008, [Online]. Available: https://sid.ir/paper/555692/en